Role of PPARG gene variants in inflammatory bowel disease
Jürgen Glas MD, MSc
Department of Human Genetics, RWTH Aachen, Germany
Department of Medicine II, Grosshadern, University of Munich, Germany
Department of Preventive Dentistry and Periodontology, University of Munich, Germany
The first two authors contributed equally to this work.
Search for more papers by this authorJulia Seiderer MD
Department of Medicine II, Grosshadern, University of Munich, Germany
The first two authors contributed equally to this work.
Search for more papers by this authorChristian Markus MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorSimone Pfennig
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorMartin Wetzke MD
Department of Pediatrics, Hannover Medical School, Germany
Search for more papers by this authorEkaterini Paschos DMD
Department of Orthodontics, University of Munich, Germany
Search for more papers by this authorBurkhard Göke MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorThomas Ochsenkühn MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorBertram Müller-Myhsok MD
Max-Planck-Institute for Psychiatry, Munich-Schwabing, Germany
Search for more papers by this authorJulia Diegelmann PhD
Department of Medicine II, Grosshadern, University of Munich, Germany
Department of Preventive Dentistry and Periodontology, University of Munich, Germany
Search for more papers by this authorDarina Roeske PhD
Max-Planck-Institute for Psychiatry, Munich-Schwabing, Germany
Search for more papers by this authorStephan Brand MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorJürgen Glas MD, MSc
Department of Human Genetics, RWTH Aachen, Germany
Department of Medicine II, Grosshadern, University of Munich, Germany
Department of Preventive Dentistry and Periodontology, University of Munich, Germany
The first two authors contributed equally to this work.
Search for more papers by this authorJulia Seiderer MD
Department of Medicine II, Grosshadern, University of Munich, Germany
The first two authors contributed equally to this work.
Search for more papers by this authorChristian Markus MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorSimone Pfennig
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorMartin Wetzke MD
Department of Pediatrics, Hannover Medical School, Germany
Search for more papers by this authorEkaterini Paschos DMD
Department of Orthodontics, University of Munich, Germany
Search for more papers by this authorBurkhard Göke MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorThomas Ochsenkühn MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this authorBertram Müller-Myhsok MD
Max-Planck-Institute for Psychiatry, Munich-Schwabing, Germany
Search for more papers by this authorJulia Diegelmann PhD
Department of Medicine II, Grosshadern, University of Munich, Germany
Department of Preventive Dentistry and Periodontology, University of Munich, Germany
Search for more papers by this authorDarina Roeske PhD
Max-Planck-Institute for Psychiatry, Munich-Schwabing, Germany
Search for more papers by this authorStephan Brand MD
Department of Medicine II, Grosshadern, University of Munich, Germany
Search for more papers by this author
Supporting Information
Additional supporting information may be found in the online version of this article.
Filename | Description |
---|---|
IBD_21425_sm_suppinfo.doc81 KB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1 Shah YM, Morimura K, Gonzalez FJ. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Am J Physiol Gastrointest Liver Physiol. 2007; 292: G657–666.
- 2 Lytle C, Tod TJ, Vo KT, et al. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm Bowel Dis. 2005; 11: 231–243.
- 3 Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008; 456: 259–263.
- 4 Sugawara K, Olson TS, Moskaluk CA, et al. Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. Gastroenterology. 2005; 128: 351–360.
- 5 Atug O, Tahan V, Eren F, et al. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease. J Gastrointest Liver Dis. 2008; 17: 433–437.
- 6 Kozaiwa K, Sugawara K, Smith MFJr, et al. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology. 2003; 125: 477–490.